Introduction |
|
1 | (13) |
|
|
4 | (1) |
|
Full Spectrum Cancer Care |
|
|
5 | (1) |
|
There's No Expiration Date |
|
|
5 | (1) |
|
|
6 | (2) |
|
|
8 | (1) |
|
|
9 | (1) |
|
I Meet Dr. Susan Ettinger (Again) |
|
|
10 | (1) |
|
How This Book Is Organized |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
12 | (1) |
|
This Book Does Not Substitute for Your Veterinarian's Guidance |
|
|
13 | (1) |
|
Part I My Dog Has Cancer Now What? |
|
|
14 | (31) |
|
|
15 | (6) |
|
|
15 | (1) |
|
First Priority: Deal with Your Emotions |
|
|
16 | (1) |
|
|
17 | (1) |
|
|
18 | (1) |
|
Reality Check Number Three |
|
|
19 | (1) |
|
|
20 | (1) |
|
Chapter 2 Mission Critical: Emotional Management |
|
|
21 | (15) |
|
Amplifying the Effects of Positive Emotions |
|
|
34 | (2) |
|
Chapter 3 Three Common Questions |
|
|
36 | (7) |
|
How Could Cancer Happen Overnight? |
|
|
36 | (1) |
|
Why Didn't My Vet Catch This Earlier? |
|
|
37 | (1) |
|
|
37 | (1) |
|
Cancer Can Start Before Birth |
|
|
38 | (1) |
|
Cancer Screening Can Be Difficult |
|
|
39 | (1) |
|
The Wait and See Approach |
|
|
39 | (1) |
|
Some Vets Don't Realize Cancer Is Epidemic |
|
|
40 | (1) |
|
Good Marketing Can Sway Opinion |
|
|
40 | (1) |
|
Conventional Medicine Does Not Offer Complete Cancer Care |
|
|
41 | (1) |
|
Is My Dog Dying Right Now? |
|
|
42 | (1) |
|
|
43 | (2) |
|
Part II What You Should Know About Dog Cancer |
|
|
45 | (58) |
|
Chapter 5 Dog Cancer Phrases, Words and Meanings |
|
|
46 | (12) |
|
Chapter 6 How Cancer Begins and Spreads |
|
|
58 | (11) |
|
|
58 | (1) |
|
|
59 | (3) |
|
|
62 | (1) |
|
|
63 | (6) |
|
|
69 | (3) |
|
|
72 | (23) |
|
|
72 | (1) |
|
|
73 | (1) |
|
Carcinogens in Commercial Dog Foods |
|
|
74 | (2) |
|
Pharmaceuticals in the Water |
|
|
76 | (1) |
|
Fluoride in Drinking Water |
|
|
77 | (1) |
|
Asbestos in Drinking Water |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
Chronic, Microscopic Inflammation |
|
|
81 | (2) |
|
|
83 | (1) |
|
|
83 | (2) |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
87 | (2) |
|
|
89 | (2) |
|
|
91 | (4) |
|
Chapter 9 How We Diagnose and Stage Cancer |
|
|
95 | (8) |
|
|
95 | (1) |
|
|
95 | (2) |
|
|
97 | (2) |
|
Get a Biopsy after a Curative Surgery |
|
|
99 | (1) |
|
|
100 | (2) |
|
|
102 | (1) |
|
Part III Full Spectrum Cancer Care |
|
|
103 | (122) |
|
Chapter 10 An Overview of Full Spectrum Care |
|
|
104 | (7) |
|
Full Spectrum Mindset and Cancer |
|
|
104 | (2) |
|
Full Spectrum Mindset and Cancer Treatments |
|
|
106 | (2) |
|
Full Spectrum Mindset and Your Vet |
|
|
108 | (1) |
|
Full Spectrum Mindset and You |
|
|
109 | (1) |
|
Five Steps to Full Spectrum Cancer Care |
|
|
109 | (1) |
|
Making Confident Choices Later |
|
|
110 | (1) |
|
Chapter 11 Step One, Conventional Treatments |
|
|
111 | (41) |
|
|
112 | (1) |
|
|
112 | (1) |
|
What Happens During Surgery |
|
|
112 | (4) |
|
|
116 | (1) |
|
|
117 | (3) |
|
|
120 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
What Happens in a Radiation Session |
|
|
123 | (2) |
|
|
125 | (1) |
|
|
125 | (2) |
|
|
127 | (2) |
|
When to Choose Chemotherapy |
|
|
129 | (1) |
|
What Happens in a Chemotherapy Session |
|
|
129 | (5) |
|
|
134 | (1) |
|
Safe Handling of Chemotherapy |
|
|
134 | (1) |
|
|
135 | (5) |
|
Managing Side effects from Conventional Therapies |
|
|
140 | (1) |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
142 | (2) |
|
Full Spectrum Ideas for Managing Side effects |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (1) |
|
|
146 | (2) |
|
|
148 | (1) |
|
|
149 | (3) |
|
Chapter 12 Step Two, Nutraceuticals |
|
|
152 | (28) |
|
|
155 | (1) |
|
|
155 | (8) |
|
|
163 | (2) |
|
|
165 | (2) |
|
|
167 | (1) |
|
|
168 | (1) |
|
|
169 | (2) |
|
Using Apocaps with Surgery, Chemotherapy and Radiation |
|
|
171 | (1) |
|
Apocaps and Other Apoptogens |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
Artemisinin and Iron-Rich Foods |
|
|
173 | (1) |
|
|
174 | (2) |
|
|
176 | (3) |
|
|
179 | (1) |
|
Chapter 13 Step Three, Immune System Boosters and Anti-Metastatics |
|
|
180 | (14) |
|
Mushroom-Derived Polysaccharides |
|
|
181 | (1) |
|
The Bottom Line on Mushroom-Derived Polysaccharides |
|
|
182 | (1) |
|
How to Give Mushroom-Derived Polysaccharides |
|
|
182 | (1) |
|
|
183 | (1) |
|
Melatonin and High Quality Sleep |
|
|
183 | (1) |
|
The Bottom Line on Melatonin |
|
|
184 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
The Bottom Line on Sunlight |
|
|
186 | (1) |
|
|
186 | (4) |
|
The Bottom Line on Multivitamins |
|
|
190 | (1) |
|
|
190 | (1) |
|
|
190 | (1) |
|
The Bottom Line on Modified Citrus Pectin |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
The Bottom Line on Doxycycline |
|
|
192 | (1) |
|
|
193 | (1) |
|
Chapter 14 Step Four, Diet |
|
|
194 | (20) |
|
|
195 | (1) |
|
|
195 | (1) |
|
Cooking Meat for Your Dog |
|
|
196 | (1) |
|
Preparing Vegetables for Your Dog |
|
|
197 | (1) |
|
|
197 | (1) |
|
Reduce Omega-6 Fatty Acids |
|
|
198 | (1) |
|
Supplement with Omega-3 Fatty Acids |
|
|
199 | (1) |
|
|
200 | (1) |
|
Weaning Your Dog to the Dog Cancer Diet |
|
|
200 | (1) |
|
The Full Spectrum Dog Cancer Diet |
|
|
201 | (1) |
|
Dog Cancer Diet Guidelines |
|
|
201 | (1) |
|
At Every Meal: High Quality Lean Protein |
|
|
202 | (1) |
|
At Every Meal: Cancer-Fighting Fats and Oils |
|
|
202 | (2) |
|
|
204 | (1) |
|
At Every Meal: Vegetables |
|
|
205 | (1) |
|
|
205 | (1) |
|
At Every Meal: Filling and Nutritious Whole Grains |
|
|
206 | (1) |
|
At Every Meal: A Dog Multivitamin |
|
|
206 | (1) |
|
At Every Meal: Optional Healthy Additions |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
208 | (1) |
|
The Full Spectrum Dog Cancer Diet Recipe |
|
|
208 | (1) |
|
Healthy Options to Add Before Serving |
|
|
209 | (1) |
|
|
210 | (2) |
|
Step Two Healthy Options at Meal Time |
|
|
212 | (1) |
|
|
212 | (2) |
|
Chapter 15 Step Five, Brain Chemistry Modification |
|
|
214 | (11) |
|
|
215 | (2) |
|
|
217 | (1) |
|
|
217 | (1) |
|
|
218 | (1) |
|
|
218 | (1) |
|
|
219 | (1) |
|
|
219 | (2) |
|
|
221 | (1) |
|
Massage and Touch Therapies |
|
|
222 | (2) |
|
|
224 | (1) |
|
Part IV Making Confident Choices |
|
|
225 | (64) |
|
Chapter 16 Dog Cancer Treatment FAQs |
|
|
226 | (3) |
|
Is all this treatment really worth it? |
|
|
226 | (1) |
|
Is this for my dog, or for me? |
|
|
227 | (2) |
|
Chapter 17 Pain and Pain Management |
|
|
229 | (5) |
|
|
234 | (2) |
|
Chapter 19 Average Life Expectancy |
|
|
236 | (3) |
|
Chapter 20 Treatment Plan Analysis |
|
|
239 | (8) |
|
|
240 | (1) |
|
|
241 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
242 | (1) |
|
|
243 | (1) |
|
|
244 | (1) |
|
|
244 | (1) |
|
|
245 | (1) |
|
|
245 | (2) |
|
Chapter 21 Choosing Treatments |
|
|
247 | (7) |
|
Step One Conventional Treatments |
|
|
247 | (1) |
|
|
248 | (1) |
|
Step Three Immune System Boosters and Anti-Metastatics |
|
|
249 | (1) |
|
|
250 | (1) |
|
Step Five Brain Chemistry Modification |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
251 | (3) |
|
Chapter 22 Working with Professionals and Loved Ones |
|
|
254 | (12) |
|
|
254 | (2) |
|
|
256 | (1) |
|
Set Aside Time to Talk to Your Vet |
|
|
256 | (1) |
|
|
257 | (1) |
|
|
257 | (1) |
|
|
258 | (2) |
|
Questions to Ask Practitioners |
|
|
260 | (2) |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
264 | (1) |
|
|
264 | (1) |
|
|
265 | (1) |
|
Chapter 23 Keep a Journal |
|
|
266 | (1) |
|
|
266 | (1) |
|
What to Track in Your Journal |
|
|
267 | (1) |
|
Chapter 24 Financial Help |
|
|
267 | (8) |
|
Organizations That May Help With Medical Bills |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
|
273 | (2) |
|
Chapter 25 End of Life Choices and Care |
|
|
275 | (11) |
|
|
275 | (1) |
|
|
275 | (2) |
|
When You're Still Not Sure |
|
|
277 | (1) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
279 | (1) |
|
|
279 | (1) |
|
|
280 | (1) |
|
|
280 | (1) |
|
|
280 | (1) |
|
Dealing with Difficult Emotions |
|
|
281 | (1) |
|
|
281 | (1) |
|
|
281 | (1) |
|
Preparing for the Appointment |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
283 | (1) |
|
|
283 | (1) |
|
|
283 | (3) |
|
Chapter 26 If Your Dog Could Speak |
|
|
286 | (2) |
|
Chapter 27 The Rest of the Book |
|
|
288 | (1) |
|
Part V From the Oncologist |
|
|
289 | (122) |
|
Chapter 28 Message from the Oncologist |
|
|
290 | (7) |
|
How an Oncologist Can Help You |
|
|
291 | (1) |
|
|
292 | (1) |
|
Chemotherapy and Radiation Side Effects |
|
|
293 | (1) |
|
|
294 | (1) |
|
|
295 | (1) |
|
|
296 | (1) |
|
|
297 | (12) |
|
|
297 | (1) |
|
Which Dogs Are at Risk for Lymphoma? |
|
|
298 | (1) |
|
What are the Signs of Lymphoma? |
|
|
299 | (1) |
|
How Is Lymphoma Diagnosed? |
|
|
299 | (2) |
|
|
301 | (1) |
|
What Is the Prognosis for Lymphoma? |
|
|
301 | (1) |
|
What Are the Available Protocols for Lymphoma? |
|
|
302 | (1) |
|
University of Wisconsin CHOP Protocol |
|
|
303 | (1) |
|
Alternative Chemotherapy Protocols |
|
|
304 | (1) |
|
Other Treatments for Lymphoma |
|
|
304 | (2) |
|
What If Lymphoma Relapses? |
|
|
306 | (1) |
|
|
307 | (2) |
|
Chapter 30 Mast Cell Tumors? |
|
|
309 | (11) |
|
What are Mast Cell Tumors? |
|
|
309 | (1) |
|
Which Dogs Are at Risk for Mast Cell Tumors? |
|
|
310 | (1) |
|
What are the Signs of Mast Cell Tumors? |
|
|
310 | (1) |
|
How Are Mast Cell Tumors Diagnosed? |
|
|
311 | (1) |
|
|
311 | (1) |
|
|
311 | (3) |
|
What Is the Prognosis for Mast Cell Tumors? |
|
|
314 | (2) |
|
What Are the Available Protocols for Mast Cell Tumors? |
|
|
316 | (2) |
|
Additional Considerations for Mast Cell Tumors |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
319 | (1) |
|
Chapter 31 Mammary Tumors? |
|
|
320 | (7) |
|
|
320 | (1) |
|
Which Dogs Are at Risk for Mammary Tumors? |
|
|
321 | (1) |
|
What are the Signs of Mammary Tumors? |
|
|
322 | (1) |
|
How Are Mammary Tumors Diagnosed? |
|
|
323 | (1) |
|
What Is the Prognosis for Mammary Tumors? |
|
|
323 | (1) |
|
What Are the Available Protocols for Mammary Tumors? |
|
|
324 | (2) |
|
Additional Considerations for Mammary Tumors |
|
|
326 | (1) |
|
|
326 | (1) |
|
|
326 | (1) |
|
|
327 | (10) |
|
|
327 | (1) |
|
Which Dogs Are at Risk for Osteosarcoma? |
|
|
328 | (1) |
|
What are the Signs of Osteosarcoma? |
|
|
329 | (1) |
|
How Is Osteosarcoma Diagnosed? |
|
|
330 | (1) |
|
What Is the Prognosis for Osteosarcoma? |
|
|
331 | (1) |
|
What Are the Available Protocols for Osteosarcoma? |
|
|
332 | (2) |
|
Additional Considerations for Osteosarcoma |
|
|
334 | (2) |
|
|
336 | (1) |
|
Chapter 33 Hemangiosarcoma |
|
|
337 | (9) |
|
|
337 | (1) |
|
Which Dogs Are at Risk for Hemangiosarcoma? |
|
|
338 | (1) |
|
What are the Signs of Hemangiosarcoma? |
|
|
338 | (1) |
|
How Is Hemangiosarcoma Diagnosed? |
|
|
339 | (2) |
|
What Is the Prognosis for Hemangiosarcoma? |
|
|
341 | (1) |
|
What Are the Available Protocols for Hemangiosarcoma? |
|
|
342 | (1) |
|
|
342 | (1) |
|
|
342 | (1) |
|
Chemotherapy for Visceral and Heart HSA |
|
|
343 | (1) |
|
|
344 | (1) |
|
Additional Considerations for Hemangiosarcoma |
|
|
344 | (1) |
|
|
345 | (1) |
|
Chapter 34 Transitional Cell Carcinoma |
|
|
346 | (7) |
|
What Is Transitional Cell Carcinoma? |
|
|
346 | (1) |
|
Which Dogs Are at Risk for Transitional Cell Carcinoma? |
|
|
347 | (1) |
|
What are the Signs of Transitional Cell Carcinoma? |
|
|
347 | (1) |
|
How Is Transitional Cell Carcinoma Diagnosed? |
|
|
348 | (1) |
|
What Is the Prognosis for Transitional Cell Carcinoma? |
|
|
349 | (1) |
|
What Are the Available Protocols for Transitional Cell Carcinoma? |
|
|
350 | (1) |
|
Additional Considerations for Transitional Cell Carcinoma |
|
|
351 | (1) |
|
|
352 | (1) |
|
|
353 | (7) |
|
|
353 | (1) |
|
Which Dogs Are at Risk for Oral Cancer? |
|
|
354 | (1) |
|
What are the Signs of Oral Cancer? |
|
|
354 | (1) |
|
How Is Oral Cancer Diagnosed? |
|
|
355 | (1) |
|
What Is the Prognosis for Oral Cancer? |
|
|
355 | (1) |
|
What Are the Available Protocols for Oral Cancer? |
|
|
356 | (1) |
|
|
357 | (1) |
|
|
357 | (1) |
|
|
358 | (1) |
|
Additional Considerations for Oral Cancer |
|
|
358 | (1) |
|
|
359 | (1) |
|
|
360 | (6) |
|
|
360 | (1) |
|
Which Dogs Are at Risk for Nasal Tumors? |
|
|
360 | (1) |
|
What are the Signs of Nasal Tumors? |
|
|
361 | (1) |
|
How Are Nasal Tumors Diagnosed? |
|
|
361 | (2) |
|
What Is the Prognosis for Nasal Tumors? |
|
|
363 | (1) |
|
What Are the Available Protocols for Nasal Tumors? |
|
|
363 | (1) |
|
Additional Considerations for Nasal Tumors |
|
|
364 | (1) |
|
|
365 | (1) |
|
Chapter 37 Soft Tissue Sarcomas |
|
|
366 | (6) |
|
What Is Soft Tissue Sarcoma? |
|
|
366 | (1) |
|
Which Dogs Are at Risk for Soft Tissue Sarcoma? |
|
|
367 | (1) |
|
What are the Signs of Soft Tissue Sarcoma? |
|
|
367 | (1) |
|
How Is Soft Tissue Sarcoma Diagnosed? |
|
|
367 | (2) |
|
What Is the Prognosis for Soft Tissue Sarcoma? |
|
|
369 | (1) |
|
What Are the Available Protocols for Soft Tissue Sarcoma? |
|
|
369 | (1) |
|
Other Considerations for Soft Tissue Sarcoma |
|
|
370 | (1) |
|
|
371 | (1) |
|
|
372 | (7) |
|
|
372 | (1) |
|
Which Dogs Are at Risk for Brain Tumors? |
|
|
373 | (1) |
|
What are the Signs of a Brain Tumor? |
|
|
373 | (1) |
|
How Is a Brain Tumor Diagnosed? |
|
|
374 | (1) |
|
What Is the Prognosis for Brain Tumors? |
|
|
374 | (1) |
|
What Are the Available Protocols for Brain Tumors? |
|
|
375 | (2) |
|
Additional Considerations for Brain Tumors |
|
|
377 | (1) |
|
|
378 | (1) |
|
Chapter 39 Perianal and Anal Sac Tumors |
|
|
379 | (7) |
|
What Are Perianal and Anal Sac Tumors? |
|
|
379 | (1) |
|
Which Dogs Are at Risk for Perianal and Anal Sac Tumors? |
|
|
380 | (1) |
|
What are the Signs of Perianal and Anal Sac Tumors? |
|
|
380 | (1) |
|
How Are Perianal and Anal Sac Tumors Diagnosed? |
|
|
381 | (1) |
|
What Is the Prognosis for Perianal and Anal Sac Tumors? |
|
|
382 | (1) |
|
What Are the Available Protocols for Perianal and Anal Sac Tumors? |
|
|
383 | (2) |
|
Additional Considerations for Perianal and Anal Sac Tumors |
|
|
385 | (1) |
|
|
385 | (1) |
|
|
386 | (9) |
|
|
386 | (1) |
|
Which Dogs Are at Risk for Melanoma? |
|
|
387 | (1) |
|
What are the Signs of Melanoma? |
|
|
387 | (1) |
|
How Is Melanoma Diagnosed? |
|
|
388 | (1) |
|
What Is the Prognosis for Melanoma? |
|
|
389 | (1) |
|
What Are the Available Protocols for Melanoma? |
|
|
389 | (1) |
|
|
389 | (2) |
|
|
391 | (1) |
|
|
392 | (1) |
|
|
392 | (2) |
|
|
394 | (1) |
|
Chapter 41 Common Veterinary Chemotherapy Drugs |
|
|
395 | (16) |
|
|
395 | (1) |
|
|
395 | (1) |
|
|
396 | (1) |
|
|
397 | (1) |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
398 | (2) |
|
|
400 | (1) |
|
|
400 | (2) |
|
|
402 | (1) |
|
|
402 | (1) |
|
|
402 | (1) |
|
|
403 | (1) |
|
|
403 | (1) |
|
|
403 | (1) |
|
|
404 | (1) |
|
Platinum-based Chemotherapy |
|
|
404 | (1) |
|
|
404 | (1) |
|
|
404 | (1) |
|
Tyrosine kinase inhibitors |
|
|
405 | (1) |
|
|
405 | (1) |
|
|
406 | (1) |
|
|
406 | (1) |
|
|
407 | (1) |
|
|
407 | (1) |
|
|
407 | (4) |
|
|
411 | (54) |
|
Appendix A The Supplement Hierarchy |
|
|
412 | (1) |
|
The Full Spectrum Supplement Hierarchy |
|
|
413 | (1) |
|
First Priority Full Spectrum Side Effect Management |
|
|
413 | (1) |
|
Second Priority Full Spectrum Nutraceuticals |
|
|
414 | (1) |
|
Third Priority Other Full Spectrum Supplements |
|
|
414 | (1) |
|
Appendix B Excluded Supplements |
|
|
415 | (2) |
|
|
417 | (1) |
|
Algae Supplements (various, including Spirulina) |
|
|
417 | (1) |
|
|
417 | (1) |
|
Antioxidants (Potent Commercial formulations such as Max GL, Poly MVA) |
|
|
417 | (1) |
|
Artichoke extracts (Cynara cardunculus) |
|
|
417 | (1) |
|
Astralagus (Astralagus membranaceous) |
|
|
418 | (1) |
|
Baical Skullcap (Scuttelaria baicalensis) |
|
|
418 | (1) |
|
|
418 | (1) |
|
|
418 | (1) |
|
Cat's Claw (Uncaria tomentosa) |
|
|
418 | (1) |
|
|
418 | (1) |
|
Co Q-10 (Coenzyme Q10, ubiquinone) |
|
|
418 | (1) |
|
|
418 | (1) |
|
|
419 | (1) |
|
|
419 | (1) |
|
|
419 | (1) |
|
EGCG and Green Tea Supplements |
|
|
419 | (1) |
|
Eleuthero (Siberian Ginseng, Eluetherococcus senticosus) |
|
|
419 | (1) |
|
|
419 | (1) |
|
Flax Seed (Linum usitatissimum) |
|
|
420 | (1) |
|
Garlic (Allium sativim) capsules |
|
|
420 | (1) |
|
Ginger supplements (Zingiber officinale) |
|
|
420 | (1) |
|
|
420 | (1) |
|
Ginseng (Panax ginseng, Panax) |
|
|
420 | (1) |
|
Grape Seed Extract (Vitis) |
|
|
420 | (1) |
|
|
420 | (1) |
|
|
421 | (1) |
|
|
421 | (1) |
|
IP-3 and IP-6 (inositol hexaphosphate) |
|
|
421 | (1) |
|
Laetrile (Vitamin B 17, amygdalin) |
|
|
421 | (1) |
|
|
421 | (1) |
|
Maritime Pine Bark Supplements |
|
|
421 | (1) |
|
Milk Thistle (Silybum marinarum) |
|
|
422 | (1) |
|
|
422 | (1) |
|
MMS (methyl methanesulfonate) |
|
|
422 | (1) |
|
|
422 | (1) |
|
Pau d'arco (Tabebuia avellanedae) |
|
|
422 | (1) |
|
|
422 | (1) |
|
|
422 | (1) |
|
|
422 | (1) |
|
Red Clover (Trifolium pratense L.) |
|
|
423 | (1) |
|
|
423 | (1) |
|
SAM-c (s-adenosyl methionine) |
|
|
423 | (1) |
|
|
423 | (1) |
|
Appendix C Helpful Resources |
|
|
424 | (1) |
|
|
425 | (1) |
|
|
425 | (1) |
|
Health Websites and Hotlines |
|
|
425 | (1) |
|
|
426 | (1) |
|
Appendix D Cancer Prevention & Longevity for Healthy Dogs |
|
|
427 | (3) |
|
Appendix E Scientific & Medical References |
|
|
430 | (35) |
Index |
|
465 | |